Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
about
A G protein-coupled receptor for UDP-glucoseIs urotensin-II the new endothelin?Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1The role of urotensin II in cardiovascular and renal physiology and diseasesUnravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffnessElevated plasma levels of human urotensin-II immunoreactivity in congestive heart failureIdentification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8The expression of urotensin II receptor (U2R) is up-regulated by interferon-gammaUrotensin II: ancient hormone with new functions in vertebrate body fluid regulationBiochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytesAssociation analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistanceRole of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstrictionUrotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenolMurine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide SymposiumContractile responses of aortae from WKY and SHR to vasoconstrictorsThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsPotent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication.Molecular subsets in the gene expression signatures of scleroderma skin.Urotensin II in chronic liver disease: in vivo effect on vascular tone.The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway.Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signallingProtein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosisEvaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients.Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cellsEndogenous urotensin II selectively modulates erectile function through eNOSUrotensin II alters vascular reactivity in animals subjected to volume overload.GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivoAddressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticityUrotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathwayComparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families.Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets.Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway.Renal impairment, hypertension and plasma urotensin II.Cardiostimulant effects of urotensin-II in human heart in vitro.Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.Urotensin-II system in genetic control of blood pressure and renal function
P2860
Q22253848-10969C58-A9AC-47D0-8E3E-D4C459E6EE53Q24672927-97B1D1AE-1E05-4923-B138-77194A4DD59DQ24674639-CD48014C-2A4A-4CEB-80ED-77C42F23EE78Q24675590-749595EE-329A-4904-AD1C-67822EE7C475Q26801739-AD62621F-F97C-46BD-B9E1-7878C1341BE9Q28177421-109BDD62-E7B8-4157-9BB0-08CED248E655Q28215417-62DB82F9-7DFB-4E27-BBD9-04AAC4173827Q28241656-DC65EAAE-5B30-4EA9-BA9E-12C2D0C922A0Q28250440-06E7BC49-6CBF-4883-B23F-7886AF1CB74BQ28260943-92206460-DC8A-46CA-8599-01E5ABFBF77FQ28478002-E9E47509-FE91-43A5-8DC1-EBA717F34A7AQ28572971-DA23F120-009D-4E57-9385-C8D64733E09BQ28573864-50377836-38F0-43AC-B957-ECC31A870E2BQ28574132-5C320EB4-3CAC-48B9-A2F6-C3BE7454B41AQ28579480-4243B8E8-9534-4C79-BCF4-F390D0E86C86Q30486707-600D7B5E-48C2-4FCF-BF72-BAFF315A9BACQ31833949-7139C76A-AA82-4B95-8268-E406217DCC8CQ33345385-8365FC8D-197D-47AA-BDE6-CBD6A4313FF1Q33354088-B06B8ECA-599E-44F2-9086-ACA782149C25Q33378279-4E6D43A2-0F06-49A6-965C-DB749CA761BFQ33599835-ED2811FD-A024-4D67-9513-726EBA44144FQ33655911-826B3C4D-1052-4643-8140-374AEC5D2571Q33991646-62C56C3A-AF47-4058-A0EC-C3090954FDFEQ34001118-ED664E55-8A24-46A1-B8FB-FDC795ACFCDBQ34007711-9A4D05CF-59BB-4917-A1CF-FC9B480F9A55Q34139078-16D8F017-4786-46B6-87D4-D1372CF6FB11Q34154714-3641542B-F3F0-4810-A439-EDB894B4B532Q34192302-5CE61539-F725-4909-BED5-FA2A343AB775Q34233981-000E343F-4761-4561-8AC4-08062FF8A110Q34238307-7F3C243D-A209-46F8-8841-EA914E002F0AQ34260110-41970A40-B421-42C3-8A2A-23767E2F3002Q34275989-C332A3B7-F95A-4A11-BD34-4563C689EC94Q34479147-D0F9839D-31C3-448B-9F62-6F668D55D07AQ34677468-F5413BD3-EFE9-41E7-BE92-1427AC3FD8AAQ34837608-1516D132-54B2-4B7D-BE62-45895A57866BQ35014906-3A67940D-1EBB-4B7C-8391-C21F7A671E90Q35025464-714779B8-2B2B-43AD-8DDF-C0DA8AE068FFQ35043105-834C88A0-D212-4B79-AD67-46F7C5DB34F8Q35047377-1CE2C49B-3EBB-46B2-998D-C3E5F50F62F1Q35082405-E9795D71-44E9-4865-91F0-37A0F8C329B6
P2860
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@ast
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en-gb
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@nl
type
label
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@ast
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en-gb
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@nl
prefLabel
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@ast
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en-gb
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@nl
P2093
P921
P3181
P356
P1433
P1476
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
@en
P2093
A M Romanic
C F Sauermelch
C S Louden
D E McNulty
D J Bergsma
E H Ohlstein
G I Glover
P2507
P2888
P3181
P356
10.1038/45809
P407
P577
1999-09-16T00:00:00Z
P6179
1005843500